Education
About Us
Working with TipRanks
Follow Us
Kristopher Hanson Insider Profile
4 Followers
Kristopher Hanson, SVP & GC at Phasebio Pharmaceuticals, holds 191.58K shares in MapLight Therapeutics, Inc. (Ticker: MPLT), holds 8.46K shares in Phasebio Pharmaceuticals (Ticker: PHASQ).
Kristopher Hanson Phasebio Pharmaceuticals (PHASQ)SVP & GC
Phasebio Pharmaceuticals (PHASQ)
SVP & GC
Not Ranked
Kristopher Hanson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kristopher Hanson's holdings
Insider Roles
GC
Roles that Kristopher Hanson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kristopher Hanson
Kristopher Hanson's Trading History
Phasebio Pharmaceuticals
May 24, 2022
―
Uninformative Buy
3.29K
$203.11
MapLight Therapeutics, Inc.
Feb 09, 2026
GC
Uninformative Buy
―
$3.42M
List of latest transactions for each holding click on a transaction to see Kristopher Hanson's performance on stock
You May Also Like
Kristopher Hanson insider profile FAQ
What is the percentage of profitable transactions made by Kristopher Hanson?
The percentage of profitable transactions made by Kristopher Hanson is ―.
What is the average return per transaction made by Kristopher Hanson?
The average return per transaction made by Kristopher Hanson is ―.
What stocks does Kristopher Hanson hold?
Kristopher Hanson holds: PHASQ, MPLT stocks.
What was Kristopher Hanson’s latest transaction?
Kristopher Hanson latest transaction was an Uninformative Buy of ―.
What was Kristopher Hanson's most profitable transaction?
Kristopher Hanson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kristopher Hanson's role in Phasebio Pharmaceuticals?
Kristopher Hanson's role in Phasebio Pharmaceuticals is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.